{Reference Type}: Journal Article
{Title}: Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist.
{Author}: Shah N;Asdourian MS;Jacoby TV;Chen ST;
{Journal}: Curr Dermatol Rep
{Volume}: 11
{Issue}: 3
{Year}: 2022
暂无{DOI}: 10.1007/s13671-022-00364-7
{Abstract}: UNASSIGNED: Neutrophilic dermatoses are a heterogeneous group of disorders with significant overlap in associated conditions, clinical presentation, and histopathologic features. This review provides a structural overview of neutrophilic dermatoses that may present in the inpatient setting along with diagnostic work-up and management strategies.
UNASSIGNED: Sweet's syndrome has been found in patients with coronavirus disease 2019 (COVID-19). Pyoderma gangrenosum (PG) has been shown to be equally associated with ulcerative colitis and Crohn's disease. A clinical trial shows that cyclosporine is equally effective as prednisone in treating PG. Neutrophilic eccrine hidradenitis has been found in the setting of newer antineoplastic medications, such as BRAF inhibitors, as well as in the setting of malignancy without chemotherapy exposure.
UNASSIGNED: Neutrophilic dermatoses are a rare and complex group of dermatoses with varying and overlapping clinical presentations. Physicians should be aware of the growing list of associated diseases in order to build a better differential diagnosis or to potentially investigate for co-existing disease.